{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:22:22Z","timestamp":1758709342738,"version":"3.37.3"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T00:00:00Z","timestamp":1570579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["REIPI RD16\/0016\/0010"],"award-info":[{"award-number":["REIPI RD16\/0016\/0010"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2017 SGR 0809"],"award-info":[{"award-number":["2017 SGR 0809"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0223326","type":"journal-article","created":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T17:30:21Z","timestamp":1570642221000},"page":"e0223326","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mutant prevention concentration of ozenoxacin for quinolone-susceptible or -resistant Staphylococcus aureus and Staphylococcus epidermidis"],"prefix":"10.1371","volume":"14","author":[{"given":"Y.","family":"L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Gargallo-Viola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cant\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8900-722X","authenticated-orcid":true,"given":"I.","family":"Zsolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,10,9]]},"reference":[{"key":"pone.0223326.ref001","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/B978-0-12-813547-1.00004-2","article-title":"Coagulase-Positive and Coagulase-Negative Staphylococci Animal Diseases","author":"F Marsilio","year":"2018","journal-title":"Pet-To-Man Travel Staphylococci"},{"issue":"2","key":"pone.0223326.ref002","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1590\/S1517-83822010000200012","article-title":"Epidemiology and antimicrobial resistance of staphylococci isolated from different infectious diseases.","volume":"41","author":"M Gad Gamal Fadl","year":"2010","journal-title":"Braz. J. Microbiol"},{"key":"pone.0223326.ref003","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/j.ijid.2012.09.006","article-title":"Characterization of methicillin-resistant Staphylococcus aureus from skin and soft tissue infections in patients in Nairobi, Kenya","volume":"17","author":"EK Maina","year":"2013","journal-title":"Int J Infect Dis"},{"key":"pone.0223326.ref004","first-page":"95","article-title":"Common skin infections in children","volume":"329","author":"MJ Sladden","year":"2004","journal-title":"Aust Fam Physician"},{"key":"pone.0223326.ref005","first-page":"555","article-title":"Staphylococcus epidermidis\u2014the \u2018accidental\u2019 pathogen","volume":"7","author":"M Otto","year":"2009","journal-title":"Nat Publ Gr"},{"issue":"2","key":"pone.0223326.ref006","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1590\/abd1806-4841.20142283","article-title":"Impetigo\u2014Review","volume":"89","author":"LB Pereira","year":"2014","journal-title":"An Bras Dermatol"},{"key":"pone.0223326.ref007","first-page":"CD003261","volume":"1","author":"S Koning","year":"2012","journal-title":"Interventions for impetigoCochrane Database of Systematic Reviews"},{"key":"pone.0223326.ref008","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/14787210.2019.1573671","article-title":"Ozenoxacin: a review of preclinical and clinical efficacy","volume":"17","author":"J Vila","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"5","key":"pone.0223326.ref009","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1073\/pnas.1814265116","article-title":"Ahmed JMet al. Sequential evolution of virulence and resistance during clonal spread of community-acquired methicillin-resistant Staphylococcus aureus","volume":"116","author":"R Copin","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"pone.0223326.ref010","first-page":"1046","article-title":"Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Pooled Analysis of Phase 3 Clinical Trials","volume":"17","author":"AA Hebert","year":"2018","journal-title":"Drugs Dermatol"},{"key":"pone.0223326.ref011","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/jac\/49.3.455","article-title":"In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone","volume":"49","author":"T Yamakawa","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"pone.0223326.ref012","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1128\/AAC.01509-13","article-title":"In vitro activity of Ozenoxacin against Gram-positive bacteria susceptible and resistant to other quinolones","volume":"57","author":"Y L\u00f3pez","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pone.0223326.ref013","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jac\/dku375","article-title":"In vitro selection of mutants resistant to ozenoxacin compared with levofloxacin and ciprofloxacin in Gram-positive cocci","volume":"70","author":"Y L\u00f3pez","year":"2014","journal-title":"J. Antimicrob. Chemother"},{"key":"pone.0223326.ref014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2217\/fmb-2017-0289","article-title":"Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolates","volume":"13","author":"R Canton","year":"2018","journal-title":"Future Microbiol"},{"key":"pone.0223326.ref015","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jiac.2016.03.006","article-title":"In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan","volume":"22","author":"S Kanayama","year":"2016","journal-title":"J Infect Chemother"},{"key":"pone.0223326.ref016","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1751-7915.2008.00063.x","article-title":"Mechanism of action of and resistance to quinolones","volume":"2","author":"A F\u00e0brega","year":"2009","journal-title":"Microb Biotechnol"},{"key":"pone.0223326.ref017","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/msb4100135","article-title":"Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli","volume":"3","author":"DJ Dwyer","year":"2007","journal-title":"Mol Syst Biol"},{"key":"pone.0223326.ref018","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jac\/dku463","article-title":"Moving forward with reactive oxygen species involvement in antimicrobial lethality","volume":"70","author":"X Zhao","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"20","key":"pone.0223326.ref019","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1073\/pnas.1901730116","article-title":"Post-stress bacterial cell death mediated by reactive oxygen species","volume":"116","author":"Y Hong","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"pone.0223326.ref020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.12830","article-title":"Mechanisms of drug resistance: quinolone resistance","volume":"1354","author":"DC Hooper","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"pone.0223326.ref021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jac\/dkg269","article-title":"The mutant selection window and antimicrobial resistance","volume":"52","author":"K Drlica","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"pone.0223326.ref022","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1086\/511642","article-title":"Mutant Selection Window Hypothesis Updated","volume":"44","author":"K Drlica","year":"2007","journal-title":"Clin Infect Dis"},{"key":"pone.0223326.ref023","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1099\/jmm.0.028654-0","article-title":"Mutant-prevention concentration and mechanism of resistance in clinical isolates and Enrofloxacin\/ marbofloxacin-selected mutants of Escherichia coli of canine origin","volume":"60","author":"E Gebru","year":"2011","journal-title":"J Med Microbiol"},{"key":"pone.0223326.ref024","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijantimicag.2004.02.021","article-title":"Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus","volume":"24","author":"K Metzler","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"pone.0223326.ref025","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/ja.2013.87","article-title":"Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis","volume":"66","author":"L Liu","year":"2013","journal-title":"J Antibiot (Tokyo)"},{"key":"pone.0223326.ref026","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1093\/jac\/dks307","article-title":"Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization","volume":"67","author":"JM Remy","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"8 Suppl","key":"pone.0223326.ref027","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.2217\/fmb.14.83","article-title":"Skin tissue exposure of once- versus twice-daily topical ozenoxacin 2% cream: a Phase I study in healthy volunteers","volume":"9","author":"S Gropper","year":"2014","journal-title":"Future Microbiol"},{"key":"pone.0223326.ref028","unstructured":"Y. L\u00f3pez, Tato M, Cant\u00f3n R and Vila J. The effect of Ozenoxacin and other quinolones on topoisomerases type II from Staphylococcus aureus and Escherichia coli. Present 53 rd Intersci Conf Antimicrob Agents Chemother (ICAAC), 2013 sep 10\u201313, Denver, USA Abstr C1-522c."},{"issue":"1","key":"pone.0223326.ref029","first-page":"146","article-title":"Acumulaci\u00f3n de Ozenoxacino y otras quinolonas en bacterias Gram Positivas","volume":"36","author":"Y L\u00f3pez","year":"2018","journal-title":"[Abstract Spanish] Abst 0280 Enferm Infecc Microbiol Clin"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0223326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T11:35:05Z","timestamp":1611488105000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0223326"}},"subtitle":[],"editor":[{"given":"D. Ashley","family":"Robinson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,10,9]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0223326","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,10,9]]}}}